Opendata, web and dolomites

ILO SIGNED

Innovative dual cycle tracking system for contraception and conception on a single device

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ILO project word cloud

Explore the words cloud of the ILO project. It provides you a very rough idea of what is the project "ILO" about.

body    fertile    menstrual    women    180    23    carbomed    self    cycle    sell    length    co2    measuring    wish    hence    overcome    stress    fulfils    seamlessly    amount    expertise    precise    tracking    periods    stage    fairly    app    combination    levels    track    first    business    count    market    none    criteria    period    golden    back    device    valued    variables    billion    pregnant    edge    exhaled    time    subjective    700    conceiving    profits    contraception    core    lack    contraceptive    temperature    handheld    predicts    conveys    million    predicting    39    facts    thanks    ovulation    tool    invasive    rely    staff    health    window    manner    reliably    progression    usually    2023    air    units    ilo    opportunity    influencing    2016    17    limitations    scientifically    subsequently    initially    monitoring    natural    cutting    algorithms    approached    accurate    innovative    child    proven    accuracy    strive    chances    fashioned    cumulative    dual    500    reaching    bleeding    relying    irregular    bespoke    commercialization   

Project "ILO" data sheet

The following table provides information about the project.

Coordinator
CARBOMED MEDICAL SOLUTIONS GMBH & CO KG 

Organization address
address: NEUE STIFTINGTALSTRASSE 2/5 OG
city: GRAZ
postcode: 8010
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Austria [AT]
 Project website https://www.iloveovulation.com/en/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-05-01   to  2018-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CARBOMED MEDICAL SOLUTIONS GMBH & CO KG AT (GRAZ) coordinator 50˙000.00

Map

 Project objective

Women usually track their menstrual cycle for three main reasons: As a natural contraceptive tool, to increase the chances of conceiving or for health-related reasons. However, monitoring every stage of the cycle in an accurate manner has proven challenging, due to the many variables influencing its progression (e.g. irregular periods, stress, etc.). Currently, there are two main approached to cycle tracking: Cycle tracking devices (which represent the old-fashioned approach, fairly reliable but require self-assessment and expertise to get accuracy), and “cutting edge” app-based cycle tracking methods (which are user-friendly, but rely in subjective facts related to the period - e.g. length or amount of bleeding-, traditional measurements -e.g. core body temperature- and algorithms, and lack accuracy. Hence, none of these approaches fulfils the “golden” criteria of being reliable, precise, simple and non-invasive. At Carbomed, we strive to overcome the limitations of both approaches thanks to our innovative ILO system, the seamlessly combination of a handheld device and an app, that reliably predicts the time of ovulation by relying on a scientifically-based method: Measuring the CO2 levels from exhaled air. ILO conveys the best features from both approaches, being accurate, simple and non-invasive while providing a user-friendly experience thanks to our bespoke app. ILO can be used as a dual cycle tracking device predicting the most fertile window, as a natural contraceptive method, but also as a tracking device for those who want to get pregnant. For Carbomed, ILO represents a large business opportunity, aimed initially at the child wish market and subsequently (and most importantly) at the contraception market valued at €17.6 billion back in 2016. In this way, we expect to sell 180,500 ILO units in the first three years of commercialization, reaching cumulative profits of €23.39 million by 2023. To reach this goal, we will increase our staff count by 700%.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ILO" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ILO" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

DNA DS (2019)

DNA Data storage

Read More  

CAARESYS (2019)

CAARESYS: vehicle passenger monitoring system based on contactless low emission radio frequency radar.

Read More  

ERGOVIAkinematix (2018)

New wearable measurement devices for Industry 4.0 based on gaming motion-capture system

Read More